FDA takes new actions to accelerate development of novel prevention, treatment options for COVID-19
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA reiterates importance of close patient supervision for 'off-label' use of antimalarial drugs
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA encourages recovered patients to donate plasma for development of blood-related therapies
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA Continues to Accelerate Development of Novel Therapies for COVID-19
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
The FDA is facilitating access to convalescent plasma collected from recovered COVID-19 patients
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA continues to facilitate development of COVID-19 treatments
- FDA and FTC warn seven companies selling fraudulent products that claim to treat or prevent COVID-19
- FDA approves new treatment for adults with Cushing's disease
- FDA approves first generic of Daraprim
- FDA takes action with Indian Government to protect consumers from illicit medical products
- FDA approves first drug for treatment of peanut allergy for children
- FDA continues strong support of innovation in development of gene therapy products